共 48 条
- [41] Lower-limb work during low- and high-impact tasks in hip-related pain: Associations with sex and symptoms (vol 24, pg S14, 2021)JOURNAL OF SCIENCE AND MEDICINE IN SPORT, 2022, 25 (03) : E3 - E3King, M.Schache, A.Semciw, A.Middleton, K.Heerey, J.Kemp, J.Sritharan, P.Scholes, M.Mentiplay, B.Crossley, K.
- [42] Impact of early intervention with onabotulinumtoxinA treatment in adult patients with post-stroke lower limb spasticity: results from the double-blind, placebo-controlled, phase 3 REFLEX studyJournal of Neural Transmission, 2020, 127 : 1619 - 1629Atul T. PatelAnthony B. WardCarolyn GeisWolfgang H. JostChengcheng LiuRozalina Dimitrova
- [43] Impact of early intervention with onabotulinumtoxinA treatment in adult patients with post-stroke lower limb spasticity: results from the double-blind, placebo-controlled, phase 3 REFLEX studyJOURNAL OF NEURAL TRANSMISSION, 2020, 127 (12) : 1619 - 1629Patel, Atul T.Ward, Anthony B.Geis, CarolynJost, Wolfgang H.Liu, ChengchengDimitrova, Rozalina
- [44] Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES) (vol 36, pg 1616, 2021)NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (04) : 805 - 805Barratt, JonathanAndric, BranislavTataradze, AvtandilSchomig, MichaelReusch, MichaelValluri, UdayaMariat, Christophe
- [45] Ivacaftor treatment of cystic fibrosis in children aged 12-< 24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study (vol 6, pg 545, 2018)LANCET RESPIRATORY MEDICINE, 2018, 6 (07): : E35 - E35Rosenfeld, M.Wainwright, C. E.Higgins, M.
- [46] Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study (vol 6, pg 545, 2018)LANCET RESPIRATORY MEDICINE, 2019, 7 (04): : E15 - E15Rosenfeld, M.Wainwright, C. E.Higgins, M.
- [47] Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study (vol 398, pg 759, 2021)LANCET, 2021, 398 (10314):Sun, J-MShen, L.Shah, M. A.
- [48] Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study (vol 8, pg e185, 2021)LANCET HIV, 2021, 8 (12): : E734 - E734Orkin, C.Oka, S.Philibert, P.